Table 3.
Study | Number of HOP sessions | Comparison condition | Study population (with psychiatric diagnoses, if available) | Setting | % female | Mean age (SD) | Race/ethnicity (if above 5%) | N (HOP, Control) | Assessments after baseline | % Dropout at first post-baseline assessment | Country |
---|---|---|---|---|---|---|---|---|---|---|---|
Conley et al. 2020 [49] | 4 (3 + 1 booster session) | TAU | College students aged 18 or older with self-reported mental illness (diagnoses not specified) | Campuses of three US universities | 82 | 21 (5) | 69% White, 18% Asian American, 8% African American | 118 (63, 55) | Post; 3-week follow-up (i.e. after the booster session for HOP participants) | 8% | USA |
Corrigan et al. 2015 [48] | 3 | TAU | Adults with self-reported mental illness (diagnoses not specified) | Multiple California communities | 64 | 46 (13) | 50% White, 27% African American, 21% Hispanic/Latino, 8% Asian, 6% Native American | 205 (107, 98; data available from: 51, 75) | Post; 1-month follow-up | 39% of randomized participants did not attend groups and/or not complete pre- and post-assessments | USA |
Mulfinger et al. 2018 [21] | 3 | TAU | Adolescents (13–18 years) with mental illness (59% depressive disorder, 17% anxiety disorder) | Inpatient (87%), day clinic (7%) and outpatient (6%) in 3 Dept.s of Child and Adolescent Psychiatry | 69 | 16 (1) | 100% White |
98 (49, 49) |
Post; 3-week follow-up | 14% | Germany |
Rüsch et al. 2014 [47] | 3 | TAU | Adults with self-reported mental illness (60% depressive disorder, 20% bipolar dis., 27% schizophrenia) | Outpatient / Community (Zürich) | 59 | 42 (11) | 100% White | 100 (50, 50) | Post; 3-week follow-up | 13% | Switzerland |
Sheehan et al. (subm. [46]) | 3 | TAU | Adults with a history of at least 1 lifetime suicide attempt (diagnoses not specified) | Community (Chicago) | 39 | 48 (14) | 82% Non-White, 18% White, 11% Hispanic/Latino | 38 (19, 19) | Post; 3-week follow-up | 8% | USA |
TAU treatment as usual, SD standard deviation, post at the end of the HOP program/after the third session, N number of randomized participants